Elizabeth Bhatt
CIK 1748622 · President and COO · last filed 2026-04-17
Elizabeth Bhatt is a President and COO who has filed 20 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing, for SEPN, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$908.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.26M
5
20
-$908.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEPN | President and COO | 174,209 | $35.95 | $6.26M | -$213.2K | 4 | 2026-04-17 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | 9,047 | $0.00 | $5 | $0 | 7 | 2024-06-13 |
| Applied Molecular Transport Inc. (AMTI) Delisted | Chief Bus. & Strategy Officer | 48,750 | $0.26 | $12.8K | -$694.7K | 5 | 2022-02-16 |
| LWACU | Director | — | $10.30 | — | $0 | 1 | 2021-01-14 |
| Achaogen, Inc. (AKAO) Delisted | Chief Operating Officer | 238,155 | — | — | -$864 | 3 | 2019-02-25 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-17 | SEPN | Mixed | — | -$70.1K | EDGAR |
| 2026-02-20 | SEPN | Mixed | — | -$88.6K | EDGAR |
| 2026-02-10 | SEPN | Grant (A) | — | $0 | EDGAR |
| 2025-08-11 | SEPN | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-21 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-16 | Applied Molecular Transport Inc. (AMTI) Delisted | Grant (A) | +17,250 | $0 | EDGAR |